Mouse Anti-MSH6 Recombinant Antibody (CBT2506) (V2LY-0625-LY1369)
 Compare
                                Online Inquiry
                                    Compare
                                Online Inquiry
                                
                            Basic Information
| Application | Note | 
| WB | 1:500-1:2,000 | 
| ELISA | 1:10,000 | 
Formulations & Storage [For reference only, actual COA shall prevail!]
Target
DNA repair Source: BHF-UCL
Intrinsic apoptotic signaling pathway Source: BHF-UCL
Intrinsic apoptotic signaling pathway in response to DNA damage Source: BHF-UCL
Isotype switching Source: BHF-UCL
Meiotic mismatch repair Source: BHF-UCL
Mismatch repair Source: UniProtKB
Negative regulation of DNA recombination Source: BHF-UCL
Positive regulation of helicase activity Source: BHF-UCL
Response to UV Source: BHF-UCL
Somatic hypermutation of immunoglobulin genes Source: BHF-UCL
Somatic recombination of immunoglobulin gene segments Source: BHF-UCL
Spermatogenesis Source: Ensembl
Other locations
Chromosome
Note: Associates with H3K36me3 via its PWWP domain.
An autosomal dominant disease associated with marked increase in cancer susceptibility. It is characterized by a familial predisposition to early-onset colorectal carcinoma (CRC) and extra-colonic tumors of the gastrointestinal, urological and female reproductive tracts. HNPCC is reported to be the most common form of inherited colorectal cancer in the Western world. Clinically, HNPCC is often divided into two subgroups. Type I is characterized by hereditary predisposition to colorectal cancer, a young age of onset, and carcinoma observed in the proximal colon. Type II is characterized by increased risk for cancers in certain tissues such as the uterus, ovary, breast, stomach, small intestine, skin, and larynx in addition to the colon. Diagnosis of classical HNPCC is based on the Amsterdam criteria: 3 or more relatives affected by colorectal cancer, one a first degree relative of the other two; 2 or more generation affected; 1 or more colorectal cancers presenting before 50 years of age; exclusion of hereditary polyposis syndromes. The term 'suspected HNPCC' or 'incomplete HNPCC' can be used to describe families who do not or only partially fulfill the Amsterdam criteria, but in whom a genetic basis for colon cancer is strongly suspected.
Endometrial cancer (ENDMC):
A malignancy of endometrium, the mucous lining of the uterus. Most endometrial cancers are adenocarcinomas, cancers that begin in cells that make and release mucus and other fluids.
Mismatch repair cancer syndrome 3 (MMRCS3):
An autosomal recessive form of mismatch repair cancer syndrome, a childhood cancer predisposition syndrome encompassing a broad tumor spectrum. This includes hematological malignancies, central nervous system tumors, Lynch syndrome-associated malignancies such as colorectal tumors as well as multiple intestinal polyps, embryonic tumors and rhabdomyosarcoma. Multiple cafe-au-lait macules, a feature reminiscent of neurofibromatosis type 1, are often found as first manifestation of the underlying cancer.
Colorectal cancer (CRC):
A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history.
Phosphorylated by PRKCZ, which may prevent MutS alpha degradation by the ubiquitin-proteasome pathway.
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon
 $30 eGift Card
$30 eGift Card
                                                
                                                Submit a review
 Loading...
Loading...
                                            Please try the standard protocols which include: protocols, troubleshooting and guide.
                                            
                                            Enzyme-linked Immunosorbent Assay (ELISA)
                                            
                                            
                                            Flow Cytometry
                                            
                                            
                                            Immunofluorescence (IF)
                                            
                                            
                                            Immunohistochemistry (IHC)
                                            
                                            
                                            Immunoprecipitation (IP)
                                            
                                            
                                            Western Blot (WB)
                                            
                                            
                                            Enzyme Linked Immunospot (ELISpot)
                                            
                                            
                                            Proteogenomic
                                            
                                            
                                            Other Protocols
                                            
                                            
                                        
Related Products
                                                
                                                Mouse Anti-MSH6 Recombinant Antibody (CBT647) (CAT#: V2LY-0625-LY3365)
                                            
Mouse Anti-MSH6 Recombinant Antibody (CBFYM-2626) (CAT#: CBMAB-M2814-FY)
Mouse Anti-MSH6 (AA 1-280) Recombinant Antibody (CBFYM-2627) (CAT#: CBMAB-M2815-FY)
Mouse Anti-MSH6 Recombinant Antibody (CF292) (CAT#: CBMAB-FT213LY)
Mouse Anti-MSH6 Recombinant Antibody (CBT2735) (CAT#: V2LY-0625-LY1343)
Mouse Anti-MSH6 Recombinant Antibody (CBT4404) (CAT#: V2LY-0625-LY1525)
Mouse Anti-MSH6 Recombinant Antibody (CBT4287) (CAT#: V2LY-0625-LY2151)
Mouse Anti-MSH6 (AA 225-333) Recombinant Antibody (44/MSH6) (CAT#: CBMAB-M2818-FY)
Mouse Anti-MSH6 (N-terminus) Recombinant Antibody (CBFYM-2629) (CAT#: CBMAB-M2817-FY)
Custom Antibody Labeling
We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).
Online InquiryContact us
 
                
